v3.26.1
Related Parties - Life Sciences Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Aug. 04, 2025
Jan. 31, 2024
Jan. 30, 2024
Related Party Transaction [Line Items]          
Share-based compensation expense $ 2,700,000 $ 3,400,000      
Accounts payable 141,400,000 84,800,000      
Life Sciences          
Related Party Transaction [Line Items]          
Revenue 12,500,000 9,800,000      
R2 Technologies | Related Party | Life Sciences          
Related Party Transaction [Line Items]          
Revenue 3,600,000 1,400,000      
Related receivables from this subsidiary 600,000 100,000      
Share-based compensation expense 300,000 1,100,000      
Accounts payable 200,000 0      
R2 Technologies | Lancer Promissory Note | Related Party | Life Sciences          
Related Party Transaction [Line Items]          
Short-term debt $ 47,900,000 $ 24,000,000.0      
Interest rate 12.00%   12.00%    
R2 Technologies | Senior Notes, Due 2025, 20.00% | Related Party | Life Sciences          
Related Party Transaction [Line Items]          
Short-term debt       $ 17,400,000  
Interest rate   20.00%   20.00% 20.00%